Peptide Titans Research Database

Peptide Research Glossary

Plain-language definitions of the terms used across peptide research documentation — analytical methods, certificate fields, chemistry basics and study models. Each entry links to a deeper guide where one exists. For laboratory research use only.

A

Amino acid

The chemical building block of peptides and proteins. Twenty standard amino acids occur in biological systems, each with a distinct side chain; a peptide’s sequence lists which amino acids it contains and in what order.

B

Batch record

The internal documentation trail for one production run of a material: inputs, dates, handling steps, and test results. Batch records are what make a lot traceable and auditable after it ships.

Bioregulator

A class of short peptides, largely described in Russian-language literature, studied for tissue-specific signaling roles. The published evidence base varies widely by compound and should be checked per peptide rather than assumed for the class.

C

CAS number

A unique identifier assigned to a chemical substance by the Chemical Abstracts Service. A CAS registry number lets researchers confirm they are reading about exactly the same compound across databases, suppliers and papers.

Certificate of Analysis (COA)

The laboratory report for one specific lot of material, typically documenting identity, purity and net content, with the test methods and date. Peptide Titans publishes its lot-specific COAs openly, matched to the lot number on the vial.

Chain of custody

The documented handoff trail of a sample from collection through testing. An intact chain of custody is what makes a laboratory result attributable to the exact material it claims to describe — explained further in why chain of custody matters.

Chromatogram

The output plot of a chromatography run: detector signal over time. Each separated component appears as a peak; peak position identifies the component and peak area quantifies it. The main peak’s share of total area underlies an HPLC purity percentage.

Clinical trial

A controlled study of an intervention in humans, conducted under regulatory oversight and typically registered publicly (for example on ClinicalTrials.gov). Cellular and animal findings do not establish clinical effects; only controlled human data can.

Counterion (salt form)

The charged partner ion that accompanies a peptide in its solid form — commonly acetate or trifluoroacetate (TFA) from purification. The salt form affects mass accounting and handling, which is why careful documentation states it.

E

Endotoxin testing

Testing for bacterial endotoxins (lipopolysaccharides), typically by LAL assay. Relevant to laboratory materials because endotoxin contamination can confound cell-based experiments even when chemical purity is high.

G

GHRH analog

A peptide structurally derived from growth-hormone-releasing hormone, studied for activity at the GHRH receptor. Examples in the research literature include sermorelin and modified GRF variants such as CJC-1295.

Growth hormone secretagogue

A compound studied for stimulating growth-hormone release, usually via the ghrelin (GHS-R1a) receptor. The class described in the literature includes GHRP-2, GHRP-6, hexarelin and ipamorelin.

H

HPLC

High-performance liquid chromatography: an analytical method that separates a sample into its components and quantifies each one. On a peptide COA, HPLC is typically the method behind the purity percentage — see HPLC testing explained.

I

Identity testing

Analysis confirming that a material is the compound its label claims — typically by mass spectrometry matching measured mass to theoretical mass. Distinct from purity: a sample can be correctly identified yet impure, or pure but misidentified. See purity vs identity.

In vitro

Latin for “in glass”: experiments performed outside a living organism, such as in cultured cells or biochemical assays. In vitro findings describe mechanisms under controlled conditions and do not by themselves establish effects in animals or humans.

In vivo

Experiments performed in a living organism, most commonly rodents in peptide research. In vivo results carry more physiological context than cell work but still require controlled human studies before any clinical conclusion can be drawn.

L

Lot number

The identifier tying a specific production run to its documentation. A COA is only meaningful when its lot number matches the vial in hand — the reasoning is laid out in why lot numbers matter.

Lyophilization

Freeze-drying: water is removed from a frozen solution under vacuum, leaving a stable powder. Peptides are commonly supplied lyophilized because the dry solid resists degradation far better than a solution during storage and transport.

M

Mass spectrometry

An analytical method that measures molecular mass with high precision. On peptide COAs it is the usual basis of identity confirmation, since a measured mass matching the theoretical mass is strong evidence the labeled compound is present — see interpreting mass spectrometry on COAs.

Melanocortin receptor agonist

A compound studied for activating one or more melanocortin receptors (MC1R–MC5R). Research-literature examples include Melanotan I (afamelanotide), Melanotan II and PT-141 (bremelanotide).

Molecular formula

The count of each element’s atoms in one molecule, written like C₆₂H₉₈N₁₆O₂₂. For peptides the formula follows from the sequence, and it determines the theoretical mass that identity testing checks against.

Molecular weight

The mass of one molecule, stated in daltons (Da). Peptide research pages usually quote the average mass of the neutral molecule; the salt form, water content and disulfide bonds all shift the number, so careful sources state their basis.

N

Net content

How much material a vial actually holds, typically verified gravimetrically. Net content is a separate question from purity — a vial can contain highly pure material in the wrong amount — which is why thorough COAs report it separately; see understanding net content.

O

Orthogonal testing

Verifying one conclusion with two independent methods — for example HPLC for purity plus mass spectrometry for identity. Because each method has blind spots, agreement across orthogonal methods is much stronger evidence than either alone; see why HPLC alone isn’t enough.

P

Peptide

A short chain of amino acids linked by peptide bonds — conventionally up to about 50 residues, beyond which the molecule is usually called a protein. A peptide’s biological behavior in research models follows from its sequence and structure.

Peptide blend

A product combining two or more compounds in one vial at stated amounts. Blends require per-component documentation, since a single purity number cannot describe a mixture.

Peptide bond

The amide bond linking one amino acid’s carboxyl group to the next amino acid’s amine group. The repeating backbone these bonds form is what defines a peptide chain.

Peptide sequence

The ordered list of amino acids in a peptide, written N-terminus to C-terminus in one-letter or three-letter code. Sequence defines identity: BPC-157’s GEPPPGKPADDAGLV is a different compound from any other arrangement of the same residues.

Preclinical research

Laboratory and animal studies conducted before any human testing. Most published peptide research is preclinical — the distinction is unpacked in preclinical vs clinical research.

PubChem CID

The compound identifier in PubChem, the National Library of Medicine’s open chemistry database. A CID links a compound to its recorded structure, synonyms and literature; large proteins often have no meaningful CID.

Purity

The percentage of a material that is the target compound, typically measured by HPLC peak area. Purity says nothing about identity or quantity on its own — what the number does and doesn’t mean is covered in peptide purity testing.

R

Reconstitution

Dissolving a lyophilized solid back into solution for laboratory use. The resulting concentration follows from the mass of material and volume of solvent. (Definition only — procedures belong to each laboratory’s own protocols.)

Research use only (RUO)

A labeling designation stating that a material is supplied for laboratory research — not for human or veterinary use. What the designation does and does not establish is explained in what research use only means.

Retention time

How long a compound takes to travel through an HPLC column and reach the detector, under stated conditions. Consistent retention time across runs of the same method supports identity; shifts flag a change in the material or the method.

S

Solubility

How readily a compound dissolves in a given solvent. Peptide solubility depends on sequence — charged residues raise water solubility, long hydrophobic stretches lower it — and documentation typically states suitable solvents for laboratory preparation.

Stability

How well a compound retains its structure over time under stated conditions. For peptides, the main enemies are heat, moisture, light and repeated freeze–thaw cycles; lyophilized solids are generally far more stable than solutions.

Sterility testing

Testing for viable microbial contamination. Distinct from chemical purity and from endotoxin testing: a chemically pure material can still carry microbial contamination, and vice versa.

Storage conditions

The temperature, light and humidity ranges under which a material maintains stability — for lyophilized peptides typically frozen storage in sealed, desiccated, light-protected containers. Each product’s documentation states its own conditions.

T

TFA content

Residual trifluoroacetic acid remaining from HPLC purification, present as the peptide’s counterion. TFA content matters in cell-based work because trifluoroacetate can affect sensitive assays, so some research protocols specify acetate salts instead.

Traceability

The ability to connect a specific vial to its production run, test results and handling history via lot numbers and batch records. Traceability is what turns a generic quality claim into a checkable one.

For laboratory research use only. Not for human or veterinary use. Educational reference information — not medical advice.